systagenix tielle hydropolymer adhesive dressing
kci medical asia pte. ltd. - general hospital - tielle® dressing is indicated for the management of low to moderately exuding wounds. tielle® dressing should be used under health care professional direction for the following indications: • pressure ulcers • lower extremity ulcers • venous • arterial • mixed aetiology • diabetic ulcers • donor sites tielle® dressing is suitable for use under compression bandaging
systagenix tielle lite hydropolymer adhesive dressing
kci medical asia pte. ltd. - general hospital - tielle® lite dressing is indicated for the management of low/non exuding and bleeding wounds. tielle® lite dressing should be used under health care professional direction for the following indications: • superficial pressure ulcers • epithelialising lower extremity ulcers • venous • arterial • mixed aetiology • diabetic ulcers • donor sites
systagenix tielle non adhesive non adhesive hydropolymer dressing
kci medical asia pte. ltd. - general hospital - tielle® non adhesive dressing is indicated for the management of low to heavily exuding wounds. tielle® non adhesive dressing should be used under health care professional direction for the following indications: lower extremity ulcers (venous, arterial, mixed aetiology), diabetic ulcers, donor sites, pressure ulcers, post-surgical or traumatic wounds. tielle® non adhesive dressing is also suitable for use under compression bandaging.
systagenix tielle packing hydropolymer dressing
kci medical asia pte. ltd. - general hospital - tielle® packing dressing is indicated for the management of chronic and deep exudating wounds, including the following: • pressure sores (all stages) • venous ulcers • diabetic foot it is specially intended to be used for patients with • very fragile skin surrounding wound • deeper cavity wounds tielle® packing dressing can be used under compression bandaging
systagenix tielle plus heel hydropolymer adhesive dressing
kci medical asia pte. ltd. - general hospital - tielle® plus heel dressing is indicated for the management of exuding wounds located on the heel. tielle® plus heel dressing should be used under health care professional direction for the following indications: • pressure ulcers • lower extremity ulcers • venous • arterial • mixed aetiology • diabetic ulcers
systagenix tielle plus hydropolymer adhesive dressing
kci medical asia pte. ltd. - general hospital - tielle® plus dressing is indicated for the management of moderate to heavily exuding wounds. tielle® plus dressing should be used under health care professional direction for the following indications: • pressure ulcers • lower extremity ulcers o venous • arterial • mixed aetiology • diabetic ulcers • donor sites tielle® plus dressing is suitable for use under compression bandaging.
systagenix tielle plus sacrum hydropolymer adhesive dressing
kci medical asia pte. ltd. - general hospital - tielle® plus sacrum dressing is indicated for the management of moderate to heavily exuding sacral wounds and other difficult to dress areas. tielle® plus sacrum dressing should be used under health care professional direction for the following indications: • sacral pressure ulcers. • difficult to dress areas
systagenix tielle xtra non-adhesive hydropolymer dressing
kci medical asia pte. ltd. - general hospital - tielle® xtra dressing is indicated for the management of low to heavily exuding wounds. tielle® xtra dressing should be used under health care professional direction for the following indications: • lower extremity ulcers o venous o arterial o mixed aetiology • diabetic ulcers • donor sites • pressure ulcers • post-surgical or traumatic wounds tielle® xtra dressing is also suitable for use under compression bandaging.
mustargen powder for solution
lundbeck pharmaceuticals llc - mechlorethamine hydrochloride - powder for solution - 10mg - mechlorethamine hydrochloride 10mg - antineoplastic agents
reg-u-late oral progestagen for horses
randlab australia pty ltd - altrenogest - oral solution/suspension - altrenogest steroid-progestin active 2.2 mg/ml - endocrine system - horse mare (female) | female horse - control of oestrus | control of ovulation